Polyphenols and ADPKD: A Further Aid from Nature?
Authors:
- Caterina CarolloCCCaterina Carollo
- Alessandra SorceASAlessandra Sorce
- Maria Elena CiuppaMCMaria Elena Ciuppa
- Emanuele CiraficiECEmanuele Cirafici
- Nicola SinatraNSNicola Sinatra
- Giulio GeraciGGGiulio Geraci
- Valentina PaternòVPValentina Paternò
- Paola Di CarloPaola Di Carlo
- Rosalia Lo PrestiRPRosalia Lo Presti
- Giuseppe MulèGiuseppe Mulè
- Gregorio CaimiGCGregorio Caimi
Open Access
Abstract
Treating autosomal dominant polycystic kidney disease (ADPKD) has always been a challenge because the disease is too complex for single-target drugs, which are often held back by side effects. This narrative review explores a different strategy: using plant-derived polyphenols to target multiple disease pathways at the same time. Looking at research from 2005 to 2026, we break down how key compounds like resveratrol, curcumin, naringenin, quercetin, and epigallocatechin-3-gallate (EGCG) actually work. Preclinical studies show these molecules can slow down cyst growth by tackling inflammation, rapid cell division, and tissue scarring all at once, while also resetting the skewed energy metabolism of cystic cells. Some mechanisms are strikingly specific, such as naringenin’s direct interaction with polycystin-2 and quercetin’s ability to clear senescent cells. Yet, the real-world hurdle is poor absorption; a recent clinical trial with standard curcumin fell short simply because the compound could not reach the kidneys in high enough concentrations. Moving forward, the field needs to focus on testing these compounds in realistic animal models, designing smart nanoformulations to improve bioavailability, and exploring combinations that could safely complement current therapies like tolvaptan.Keywords
This publication has 100 references indexed in Scilit:
- Quercetin supplementation prevents kidney damage and improves long‐term prognosis in hypertensive patientsPhytotherapy Research, 2024
- Quercetin prevented diabetic nephropathy by inhibiting renal tubular epithelial cell apoptosis via the PI3K/AKT pathwayPhytotherapy Research, 2024
- Exome Sequencing of a Clinical Population for Autosomal Dominant Polycystic Kidney DiseaseJAMA, 2022
- Natural-derived compounds and their mechanisms in potential autosomal dominant polycystic kidney disease (ADPKD) treatmentClinical and Experimental Nephrology, 2021
- Inflammation and Fibrosis in Polycystic Kidney Disease2017
- Inflammation and Fibrosis in ADPKD2016
- Resveratrol content and antioxidant properties of underutilized fruitsJournal of Food Science and Technology, 2013
- Elevated TGFβ–Smad signalling in experimental Pkd1 models and human patients with polycystic kidney diseaseThe Journal of Pathology, 2010
- Vascular Effects of Cocoa Rich in Flavan-3-olsJAMA, 2003
- Review of the biology of quercetin and related bioflavonoidsFood and Chemical Toxicology, 1995